![]() |
![]() |
(4R)-4-({3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl}Methyl)-1,3-oxazolidin-2-one (4r)-4-[[3-(2-dimethylaminoethyl)-1h-indol-5-yl]methyl]oxazolidin-2-one (4S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one (S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)- AscoTop Assists Mi Qu Pu Tanzania BW 311C90 MFCD00871503 Zolmitriptan (150 mg) ZolMitriptan API ZolMitriptan(ZoMig) ZOLMITRIPTANE Zomig Zomigon Zomigoro
Hazard Codes:? Xi
The Risk Statements information of? Zolmitriptan:
36/37/38:? Irritating to eyes, respiratory system and skin?
The Safety Statements information of? Zolmitriptan:
26:? In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36:? Wear suitable protective clothing
? Zolmitriptan , with CAS number of 139264-17-8, can be called (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone ; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone ; 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-, (S)- ; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone .?The usage of Zolmitriptan is as an serotonin 5HTID-receptor agonist.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
women | TDLo | oral | 6mg/kg/43W-I (6mg/kg) | BEHAVIORAL: HEADACHE | Lancet. Vol. 353, Pg. 378, 1999. ? |
Acute toxicity - Oral, Category 4
Pictogram(s) | ![]() |
---|---|
Signal word | Warning |
Hazard statement(s) | H302 Harmful if swallowed |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. |
Response | P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/\u2026if you feel unwell. P330 Rinse mouth. |
Storage | none |
Disposal | P501 Dispose of contents/container to ... |
none
![]() |
Literatures:
LABORATORIOS VITA, S. A. Patent: WO2004/14901 A1, 2004 ; Location in patent: Page 18-19 ; ![]() Yield: ~87% |
![]() |
![]() |